Lenalidomide, melphalan, and prednisone association is an effective salvage therapy in relapsed plasma cell leukaemia.
about
Primary plasma cell leukemia 2.0: advances in biology and clinical management.Plasma cell leukemia.How I treat plasma cell leukemia.Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.Primary Plasma Cell Leukemia: Identity Card 2016.Plasma cell leukemia: update on biology and therapy.
P2860
Lenalidomide, melphalan, and prednisone association is an effective salvage therapy in relapsed plasma cell leukaemia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Lenalidomide, melphalan, and p ...... elapsed plasma cell leukaemia.
@en
Lenalidomide, melphalan, and p ...... elapsed plasma cell leukaemia.
@nl
type
label
Lenalidomide, melphalan, and p ...... elapsed plasma cell leukaemia.
@en
Lenalidomide, melphalan, and p ...... elapsed plasma cell leukaemia.
@nl
prefLabel
Lenalidomide, melphalan, and p ...... elapsed plasma cell leukaemia.
@en
Lenalidomide, melphalan, and p ...... elapsed plasma cell leukaemia.
@nl
P2093
P2860
P356
P1433
P1476
Lenalidomide, melphalan, and p ...... elapsed plasma cell leukaemia.
@en
P2093
Emilia Giugliano
Giuseppe Saglio
Roberta Merlini
Tommasina Guglielmelli
P2860
P304
P356
10.1155/2009/867380
P577
2009-01-01T00:00:00Z